Author: Pischel, Lauren; Walelo, Makeda; Benson, Jemma; Osborn, Rebecca; Schrier, Rachel; Tuan, Jessica; Barakat, Lydia; Ogbuagu, Onyema
Title: Race and ethnicity do not impact eligibility for remdesivir: A single-center experience Cord-id: mofjc2o2 Document date: 2021_5_6
ID: mofjc2o2
Snippet: As the Coronavirus-2019 (COVID-19) pandemic continues, multiple therapies are rapidly being evaluated for efficacy in clinical trials. Clinical trials should be racially and ethnically representative of the population that will eventually benefit from these medications. There are multiple potential barriers to racial and ethnic minority enrollment in clinical trials, one of which could be that inclusion and exclusion criteria select for certain racial or ethnic groups disproportionately. In this
Document: As the Coronavirus-2019 (COVID-19) pandemic continues, multiple therapies are rapidly being evaluated for efficacy in clinical trials. Clinical trials should be racially and ethnically representative of the population that will eventually benefit from these medications. There are multiple potential barriers to racial and ethnic minority enrollment in clinical trials, one of which could be that inclusion and exclusion criteria select for certain racial or ethnic groups disproportionately. In this observational cohort study at a single health care system, we examined if there were differences in eligibility for treatment with remdesivir based on clinical trial criteria for racial and ethnic minorities compared to non-Hispanic Whites. 201 electronic medical record charts were reviewed manually. Self-identified Whites were older than other racial or ethnic groups. At the time of presentation, Black, Latinx, and White participants met inclusion criteria for remdesivir at similar rates (72%, 80%, and 73% respectively), and exclusion criteria at similar rates (43%, 38% and 49% for Black, Latinx and White participants respectively). In this study, there was no difference in eligibility for remdesivir based on race or ethnicity alone.
Search related documents:
Co phrase search for related documents- absolute value and admission time: 1, 2, 3
- absolute value and liver function: 1
- admission course and liver disease: 1, 2, 3, 4, 5, 6
- admission course and liver function: 1, 2, 3
- admission course and liver function test: 1
- admission course and liver injury: 1, 2, 3, 4, 5, 6, 7, 8
- admission course and liver injury risk: 1, 2, 3
- admission day and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- admission day and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- admission day and liver function test: 1, 2
- admission day and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- admission day and liver injury risk: 1
- admission day and lung liver: 1, 2
- admission time and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- admission time and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- admission time and liver function test: 1, 2, 3
- admission time and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- admission time and liver injury risk: 1, 2
- liver disease and lung liver: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53
Co phrase search for related documents, hyperlinks ordered by date